Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 2/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.41 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.41 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.41 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21740964 | 0.81 | SLC6A4 (0.42) | RIPK1SLC6A3SLC6A4CACNA1FCHRM2 | |
| SCHEMBL18470550 | 0.79 | TAAR1 (0.50) | RIPK1SLC6A3SLC6A4CACNA1FCHRM2 | |
| SCHEMBL416895 | 0.79 | TAAR1 (0.50) | RIPK1SLC6A3SLC6A4CACNA1FCHRM2 | |
| SCHEMBL14431333 | 0.79 | TAAR1 (0.50) | RIPK1SLC6A3SLC6A4CACNA1FCHRM2 | |
| SCHEMBL20306752 | 0.77 | RIPK1 (0.45) | RIPK1SLC6A3SLC6A4CACNA1FCHRM2 | |
| SCHEMBL1471159 | 0.75 | SLC6A4 (0.45) | RIPK1SLC6A3SLC6A4CACNA1FCHRM2 | |
| SCHEMBL11968994 | 0.75 | TAAR1 (0.44) | RIPK1SLC6A3SLC6A4CACNA1FCHRM2 | |
| SCHEMBL6609543 | 0.75 | RIPK1 (0.43) | RIPK1SLC6A3SLC6A4CACNA1FCHRM2 | |
| SCHEMBL30923543 | 0.75 | SLC6A4 (0.45) | RIPK1SLC6A3SLC6A4CACNA1FCHRM2 | |
| SCHEMBL12574668 | 0.75 | SLC6A4 (0.45) | RIPK1SLC6A3SLC6A4CACNA1FCHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11718614-B2 | Compounds and methods for treatment of hedgehog pathway associated conditions | SUZHOU MEDNES PHARMA TECH CO., LTD. (CN) | 2023-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718614-B2 | Compounds and methods for treatment of hedgehog pathway associated conditions | SHH, GLI1, SMO | RIPK1 1473/4885SLC6A3 2687/4885SLC6A4 3643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.